Chunyu Zeng Selected Research

Tirofiban (Aggrastat)

1/2016	Tirofiban induces vasorelaxation of the coronary artery via an endothelium-dependent NO-cGMP signaling by activating the PI3K/Akt/eNOS pathway.
8/2015	Protective effects of tirofiban on ischemia/reperfusion-induced renal injury in vivo and in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunyu Zeng Research Topics

Disease

57	Hypertension (High Blood Pressure) 04/2024 - 10/2003
19	Myocardial Infarction 04/2024 - 07/2012
14	Inflammation (Inflammations) 12/2023 - 03/2013
13	Atherosclerosis 01/2024 - 06/2014
10	Reperfusion Injury 12/2023 - 10/2013
9	Essential Hypertension 01/2023 - 11/2004
8	Hypoxia (Hypoxemia) 01/2022 - 07/2013
7	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 10/2015
7	Obesity 04/2024 - 02/2014
6	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 04/2010
6	Ischemia 01/2022 - 10/2013
5	Vascular Diseases (Vascular Disease) 11/2023 - 05/2009
5	Vascular Remodeling 10/2022 - 01/2015
5	Infarction (Infarctions) 01/2021 - 01/2013
4	Wounds and Injuries (Trauma) 01/2022 - 07/2014
4	Fibrosis (Cirrhosis) 11/2021 - 02/2013
3	Neoplasms (Cancer) 03/2024 - 03/2015
3	Atherosclerotic Plaque (Atheroma) 01/2024 - 10/2014
3	Cardiomegaly (Heart Hypertrophy) 03/2023 - 02/2013
3	Insulin Resistance 01/2023 - 01/2021
3	Stroke (Strokes) 01/2022 - 04/2010
3	Diabetes Mellitus 01/2022 - 10/2016
3	Cicatrix (Scar) 11/2021 - 10/2015
3	Hyperplasia 10/2019 - 01/2014
3	Myocardial Ischemia (Ischemic Heart Diseases) 12/2018 - 07/2013
2	Coronary Disease (Coronary Heart Disease) 04/2024 - 12/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 03/2024 - 09/2015
2	Edema (Dropsy) 12/2023 - 01/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 06/2015
2	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2021 - 01/2021
2	Hyperglycemia 10/2019 - 02/2014
2	Heart Failure 04/2019 - 02/2013
2	Body Weight (Weight, Body) 01/2019 - 01/2016
2	Unstable Angina 12/2018 - 08/2015
2	Pathologic Constriction (Stenosis) 01/2018 - 09/2011
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2018 - 04/2014
2	Acute Coronary Syndrome 01/2016 - 01/2014

Drug/Important Bio-Agent (IBA)

20	SodiumIBA 01/2023 - 10/2003
18	Dopamine Receptors (Dopamine Receptor)IBA 01/2023 - 03/2004
14	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2014
12	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 10/2003
11	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022 - 10/2006
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2012
8	Therapeutic UsesIBA 12/2022 - 01/2016
8	AngiotensinsIBA 01/2019 - 01/2005
7	GastrinsIBA 09/2023 - 11/2013
7	Insulin (Novolin)FDA Link 01/2023 - 05/2009
7	Long Noncoding RNAIBA 10/2022 - 10/2014
6	G-Protein-Coupled Receptor Kinase 4IBA 01/2023 - 06/2015
6	SaltsIBA 11/2022 - 11/2004
6	Hormones (Hormone)IBA 01/2016 - 10/2006
5	Apolipoproteins E (ApoE)IBA 01/2021 - 10/2014
5	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2020 - 11/2014
5	ReninIBA 01/2019 - 01/2005
4	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2019
4	CytokinesIBA 12/2023 - 12/2016
4	AntioxidantsIBA 03/2023 - 02/2015
4	Type 1 Angiotensin ReceptorIBA 01/2023 - 04/2015
4	Phosphotransferases (Kinase)IBA 01/2023 - 12/2018
4	Antihypertensive Agents (Antihypertensives)IBA 11/2022 - 01/2016
4	Messenger RNA (mRNA)IBA 01/2017 - 01/2014
4	Small Interfering RNA (siRNA)IBA 12/2016 - 07/2013
3	oxidized low density lipoproteinIBA 04/2024 - 01/2013
3	candesartanIBA 01/2023 - 06/2015
3	G-Protein-Coupled Receptor KinasesIBA 11/2022 - 06/2006
3	Peptides (Polypeptides)IBA 10/2022 - 02/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2013
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2013
3	Particulate MatterIBA 11/2021 - 01/2018
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021 - 03/2016
3	Insulin ReceptorIBA 01/2018 - 06/2011
3	Vasopressins (Vasopressin)IBA 02/2008 - 01/2005
2	LDL CholesterolIBA 04/2024 - 06/2015
2	Peroxidase (Myeloperoxidase)IBA 12/2023 - 01/2016
2	AcidsIBA 12/2023 - 06/2015
2	LipopolysaccharidesIBA 09/2023 - 10/2022
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 03/2023 - 02/2013
2	Dopamine D5 ReceptorsIBA 01/2023 - 01/2020
2	Metformin (Glucophage)FDA LinkGeneric 12/2022 - 01/2017
2	Angiotensin IIIBA 10/2022 - 02/2016
2	tempolIBA 10/2022 - 02/2015
2	MicroRNAs (MicroRNA)IBA 12/2021 - 07/2012
2	Circular RNAIBA 12/2021 - 01/2019
2	Urea (Carbamide)FDA LinkGeneric 01/2021 - 01/2016
2	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 01/2021 - 10/2019
2	Epoxide HydrolasesIBA 01/2021 - 01/2017
2	Sorting NexinsIBA 01/2020 - 01/2019
2	LipidsIBA 01/2019 - 06/2015
2	Troponin IIBA 12/2018 - 12/2016
2	CurcuminIBA 01/2018 - 01/2016
2	EnzymesIBA 01/2017 - 03/2016
2	Tirofiban (Aggrastat)FDA Link 01/2016 - 08/2015
2	Glycoproteins (Glycoprotein)IBA 01/2016 - 08/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 01/2014
2	antineoplaston A10 (A 10)IBA 01/2016 - 10/2003

Therapy/Procedure

15	Therapeutics 03/2024 - 04/2010
6	Percutaneous Coronary Intervention 01/2021 - 04/2010
4	Intravenous Administration 09/2023 - 01/2016
4	Transplantation 01/2017 - 01/2013
3	Stents 03/2018 - 09/2011